Skip to search formSkip to main contentSkip to account menu

Anal Canal Neuroendocrine Carcinoma

Known as: Anal Canal NEC G3, Anal Neuroendocrine Carcinoma, Anal Canal NEC 
An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the anal canal. The mitotic count… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
321 Background: G3 NENs are aggressive, and optimal systemic treatment is unclear. Temozolomide (TEM)-based regimens have been… 
2014
2014
Hepatitis E virus (HEV) infection can be responsible for chronic hepatitis in immunocompromised patients, and can rapidly evolve… 
2012
2012
This study tries to Analysis for allocation of Corporate Social Responsibility’s funds and reporting of sustainability report… 
2009
2009
5037^ Background: RAD001 (everolimus) and sunitinib (SUTENT) both have activity in metastatic renal cell carcinoma (mRCC… 
1989
1989
Monoclonal antibody CA-50 is a useful tumour marker in gastrointestinal carcinoma. We report an assessment of its value in…